Changes in Cardiovascular Biomarkers Associated With the Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes.
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment.
18 - Empagliflozin Is Associated With Increased Plasma Lipid Metabolites in Type 1 Diabetes...Virtual Diabetes Canada/CSEM Professional Conference, October 28-30, 2020
Relationships Between Inflammation, Hemodynamic Function and RAAS in Longstanding Type 1 Diabetes and Diabetic Kidney Disease
Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease.
Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.